Related Experiment Video
Updated: Jul 2, 2026

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
Olfactory deficits in mice overexpressing human wildtype alpha-synuclein
Sheila M Fleming1, Nicole A Tetreault, Caitlin K Mulligan
1Department of Neurology and Neurobiology, The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA 90095-1769, USA. sfleming@ucla.edu
The European Journal of Neuroscience
|August 16, 2008
Summary
Overexpression of alpha-synuclein in mice causes olfactory deficits, mimicking early Parkinson's disease (PD) symptoms. These mice and tests are valuable for developing new PD neuroprotective therapies.
Area of Science:
- Neuroscience
- Neurodegenerative Diseases
- Parkinson's Disease Research
Background:
- Alpha-synuclein aggregation is central to Parkinson's disease (PD) pathogenesis.
- Olfactory dysfunction is an early, pre-motor symptom in human PD patients.
- Thy1-aSyn transgenic mice model pre-clinical PD stages with high alpha-synuclein expression.
Purpose of the Study:
- To investigate olfactory function in Thy1-aSyn mice.
- To assess alpha-synuclein pathology in the olfactory bulb.
- To evaluate olfactory tests for PD therapeutic screening.
Main Methods:
- Utilized buried pellet, block, and habituation/dishabituation tests to assess olfactory function in 3- and 9-month-old Thy1-aSyn mice.
- Examined alpha-synuclein immunoreactivity and proteinase K-resistant inclusions in the olfactory bulb.
- Compared olfactory performance and pathology between Thy1-aSyn mice and wildtype littermates.
Main Results:
- Thy1-aSyn mice exhibited olfactory impairments across all tested paradigms, despite intact odor detection and habituation.
- Proteinase K-resistant alpha-synuclein inclusions were found throughout the olfactory bulb in Thy1-aSyn mice.
- The buried pellet and block tests demonstrated high sensitivity for detecting drug effects.
Conclusions:
- Alpha-synuclein overexpression is sufficient to induce olfactory deficits in mice, mirroring human PD.
- Thy1-aSyn mice serve as a relevant model for studying early PD olfactory dysfunction.
- The employed olfactory tests are suitable for preclinical screening of neuroprotective agents for Parkinson's disease.

